Life360, Inc. (NASDAQ:LIF – Get Free Report) Director Mark Goines sold 50,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $40.70, for a total transaction of $2,035,000.00. Following the sale, the director now directly owns 76,272 shares in the company, valued at $3,104,270.40. This represents a 39.60 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Mark Goines also recently made the following trade(s):
- On Monday, November 25th, Mark Goines sold 10,000 shares of Life360 stock. The stock was sold at an average price of $43.89, for a total transaction of $438,900.00.
Life360 Trading Up 6.7 %
Shares of NASDAQ LIF opened at $49.45 on Friday. The stock’s 50-day simple moving average is $42.78. Life360, Inc. has a fifty-two week low of $26.00 and a fifty-two week high of $49.50.
Analyst Upgrades and Downgrades
View Our Latest Research Report on LIF
Institutional Trading of Life360
Institutional investors have recently modified their holdings of the stock. Wealthstream Advisors Inc. purchased a new position in shares of Life360 in the 3rd quarter valued at $35,538,000. Regal Partners Ltd purchased a new position in shares of Life360 during the second quarter worth about $23,635,000. Millennium Management LLC purchased a new position in shares of Life360 during the second quarter worth about $11,861,000. Ghisallo Capital Management LLC acquired a new stake in shares of Life360 during the second quarter worth about $8,098,000. Finally, Emerald Advisers LLC purchased a new stake in shares of Life360 in the 2nd quarter valued at about $6,777,000.
About Life360
Life360 Inc is a family connection and safety company. Its business category includes mobile app and Tile tracking devices with a range of services, including location sharing, safe driver reports and crash detection with emergency dispatch. Life360 Inc is based in SAN FRANCISCO.
See Also
- Five stocks we like better than Life360
- Investing in Travel Stocks Benefits
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What Are Growth Stocks and Investing in Them
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Technology Stocks Explained: Here’s What to Know About Tech
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Life360 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life360 and related companies with MarketBeat.com's FREE daily email newsletter.